Abstract
Development of RGD-modified nanoparticles with epigallocatechin gallate (EGCG) loading as ophthalmic nanomedicine to inhibit corneal neovascularization development
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have